Ispronicline

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIspronicline
Drug Alias Name异丙克兰isproniclinaisproniclinumAZD-3480TC-1734 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor; alpha4/beta2 agonists
TargetsNeuronal acetylcholine receptor alpha4/beta2 complex
Therapy Area/IndicationsSchizophreniaAttention Deficit Disorder with HyperactivityMemory Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[15] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesTargacept Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co LtdAstrazeneca Uk LtdAstrazeneca Plc +[5] 
Active IndicationsN/A
Inactive IndicationsSchizophreniaAttention Deficit Disorder with HyperactivityMemory Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG